Jack W. Scannell

5.8k total citations · 2 hit papers
28 papers, 3.7k citations indexed

About

Jack W. Scannell is a scholar working on Cognitive Neuroscience, Economics and Econometrics and Cellular and Molecular Neuroscience. According to data from OpenAlex, Jack W. Scannell has authored 28 papers receiving a total of 3.7k indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Cognitive Neuroscience, 7 papers in Economics and Econometrics and 4 papers in Cellular and Molecular Neuroscience. Recurrent topics in Jack W. Scannell's work include Neural dynamics and brain function (14 papers), Functional Brain Connectivity Studies (10 papers) and Visual perception and processing mechanisms (9 papers). Jack W. Scannell is often cited by papers focused on Neural dynamics and brain function (14 papers), Functional Brain Connectivity Studies (10 papers) and Visual perception and processing mechanisms (9 papers). Jack W. Scannell collaborates with scholars based in United Kingdom, United States and Germany. Jack W. Scannell's co-authors include Brian Warrington, Thomas P. Curtis, William T. Sloan, Malcolm P. Young, Claus C. Hilgetag, Gully Burns, Jim Bosley, Mark A. O’Neill, M. P. Young and Colin Blakemore and has published in prestigious journals such as Nature, Proceedings of the National Academy of Sciences and PLoS ONE.

In The Last Decade

Jack W. Scannell

28 papers receiving 3.5k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Diagnosing the decline in pharmaceutical R&D efficiency

2012 1.3k citations Jack W. Scannell, Brian Warrington et al. Nature Reviews Drug Discovery profile →
Estimating prokaryotic diversity and its limits

2002 773 citations Thomas P. Curtis, William T. Sloan et al. Proceedings of the National Academy of Sciences profile →

Peers

Countries citing papers authored by Jack W. Scannell

Since Specialization

Citations

This map shows the geographic impact of Jack W. Scannell's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jack W. Scannell with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jack W. Scannell more than expected).

Fields of papers citing papers by Jack W. Scannell

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jack W. Scannell. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jack W. Scannell. The network helps show where Jack W. Scannell may publish in the future.

Co-authorship network of co-authors of Jack W. Scannell

This figure shows the co-authorship network connecting the top 25 collaborators of Jack W. Scannell. A scholar is included among the top collaborators of Jack W. Scannell based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jack W. Scannell. Jack W. Scannell is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Costs and Causes of Oncology Drug Attrition With the Example of Insulin-Like Growth Factor-1 Receptor Inhibitors 2023 ·JAMA Network Open ·(unknown), Leeza Osipenko, Jack W. Scannell, John A. Hickman	22
2	Predictive validity in drug discovery: what it is, why it matters and how to improve it 2022 ·Nature Reviews Drug Discovery ·Jack W. Scannell, Jim Bosley, John A. Hickman, Gerard R. Dawson, Hubert Truebel, Guilherme S. Ferreira, Duncan Richards, J. Mark Treherne	47
3	Biopharmaceutical R&D outsourcing: Short-term gain for long-term pain? 2022 ·Drug Discovery Today ·Étienne Billette de Villemeur, Jack W. Scannell, (unknown)	1
4	Breaking Eroom’s Law 2020 ·Nature Reviews Drug Discovery ·Michael S. Ringel, Jack W. Scannell, (unknown), Ulrik Schulze	63
5	Regulatory and market influences on innovation pathways for the development of new antimicrobial drugs 2019 ·Technology Analysis and Strategic Management ·James Mittra, Ann Bruce, Jack W. Scannell, Joyce Tait	3
6	Evidence for the effectiveness of minimum pricing of alcohol: a systematic review and assessment using the Bradford Hill criteria for causality 2017 ·BMJ Open ·Sadie Boniface, Jack W. Scannell, Sally Marlow	44
7	When Quality Beats Quantity: Decision Theory, Drug Discovery, and the Reproducibility Crisis 2016 ·PLoS ONE ·Jack W. Scannell, Jim Bosley	180
8	Financial Returns on R&D: Looking Back at History, Looking Forward to Adaptive Licensing 2015 ·Reviews on Recent Clinical Trials ·Jack W. Scannell, (unknown), (unknown)	8
9	The Life Sciences Translational Challenge: The European Perspective 2014 ·Therapeutic Innovation & Regulatory Science ·Richard Barker, Jack W. Scannell	3
10	Diagnosing the decline in pharmaceutical R&D efficiency breakdown → 2012 ·Nature Reviews Drug Discovery ·Jack W. Scannell, (unknown), (unknown), Brian Warrington	1264
11	Correlations, feature-binding and population coding in primary visual cortex 2003 ·Neuroreport ·Huw Golledge, Stefano Panzeri, (unknown), (unknown), Jack W. Scannell, (unknown), Roger J. Mason, Martin J. Tovée, Malcolm P. Young	41
12	Correlations, feature-binding and population coding in primary visual cortex 2003 ·Neuroreport ·Huw Golledge, Stefano Panzeri, (unknown), (unknown), Jack W. Scannell, (unknown), Roger J. Mason, Martin J. Tovée, Malcolm P. Young	34
13	Estimating prokaryotic diversity and its limits breakdown → 2002 ·Proceedings of the National Academy of Sciences ·Thomas P. Curtis, William T. Sloan, Jack W. Scannell	773
14	The smell map: is there a commonality of odour perception?1 1999 ·Clinical Otolaryngology ·Sean Carrie, Jack W. Scannell, Patrick Dawes	9
15	The Connectional Organization of the Cortico-thalamic System of the Cat 1999 ·Cerebral Cortex ·Jack W. Scannell	279
16	Neuronal population activity and functional imaging 1999 ·Proceedings of the Royal Society B Biological Sciences ·Jack W. Scannell, Malcolm P. Young	53
17	Non-metric multidimensional scaling in the analysis of neuroanatomical connection data and the organization of the primate cortical visual system 1995 ·Philosophical Transactions of the Royal Society B Biological Sciences ·M. P. Young, Jack W. Scannell, Mark A. O’Neill, Claus C. Hilgetag, Gully Burns, Colin Blakemore	62
18	The Analysis of Cortical Connectivity 1995 ·Medical Entomology and Zoology ·etc., Malcolm P. Young, Gully Burns, Jack W. Scannell	66
19	Scaling and brain connectivity 1994 ·Nature ·Malcolm P. Young, Jack W. Scannell, Gully Burns, Colin Blakemore	4
20	The connectional organization of neural systems in the cat cerebral cortex 1993 ·Current Biology ·Jack W. Scannell, Malcolm P. Young	80

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact